ARCHIVES

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 01 | January 6, 1989

Download PDF Visit The Full Archive

Related Articles

Black Men Face Disparate Cancer Burden; Minority Rates Vary, Klausner Tells House

April 3, 1998

Letter to the Editors: Researchers Must Keep Up NIH Advocacy Particularly Now

October 11, 1996

Letter To the Editor: Screening Revisited

May 20, 1994

To Cut Colon Cancer Deaths, Reduce Barriers To Screening, NIH Panel Says

February 5, 2010

Clinical Trials: NCI Removes Brooklyn Site From PLCO Trials

October 24, 1997

NCI Asks $955 Million In ’78; HEW Says $799 Will Be Enough

August 20, 1976